Roche Holding AG (RHHBF)

381.50 +13.00 (+3.53%) As of 09:30AM EDT. Market open.

Roche Holding AG

Konzern Hauptsitz
Grenzacherstrasse 124
Basel 4070
Switzerland
41 61 688 11 11
https://www.roche.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 100,920

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Severin Schwan Ph.D.	CEO & Exec. Director	7.71M	N/A	1967
Dr. Alan Hippe	Chief Financial & Information Officer	4.42M	N/A	1967
Ms. Cristina A. Wilbur	Chief People Officer	3.16M	N/A	1967
Dr. Johannes Carolus Clevers M.D., Ph.D.	Head of Roche Pharma Research & Early Devel.	359.02k	N/A	1957
Dr. Thomas Schinecker	Chief Exec. Officer of Roche Diagnostics	3.03M	N/A	1975
Mr. William N. Anderson	Chief Exec. Officer of Roche Pharmaceuticals	6.66M	N/A	1966
Dr. Karl Mahler	Head of Investor Relations	N/A	N/A	N/A
Ms. Claudia Bockstiegel	Gen. Counsel	N/A	N/A	1964
Ms. Pascale Schmidt	Chief Compliance Officer	N/A	N/A	1973
Ms. Barbara Schadler	Head of Group Communications	N/A	N/A	1962

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company also has a collaboration with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Corporate governance

Roche Holding AG’s ISS governance QualityScore as of 1 May 2022 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.